FindTrial
Sign In

PROVIDING OXYGEN BY NASAL PRONGS AT FLOW MORE THAN 2 LITRES PER MINUTE VERSUS PROVIDING OXYGEN WITH NASAL PRONGS USING CPAP DEVICE IN CHILDREN WITH DIFFICULTY IN BREATHING.

TO COMPARE OUTCOMES OF HUMIDIFIED HIGH FLOW NASAL CANNULA VERSUS NASAL CONTINOUS POSITIVE AIRWAY PRESSURE IN CHILDREN WITH RESPIRATORY DISTRESS:A RANDOMISED CONTROLLED TRIAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052491
Enrollment
70
Registered
2023-05-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: High Flow Nasal Cannula (HFNC): Eligible Patients Randomized to receive Intervention will be provided high flow oxygen Using MR850 Fischer and Paykel Health Care System. FIo2 from 0.21

Sponsors

Motukuri Sesha Sarat Chandra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children from 1 month to 18 years having Respiratory distress

Exclusion criteria

Exclusion criteria: Intubation on admission Children with congenital heart diseases Children with neurological diseases Covid positive patients Children with chest wall deformity

Design outcomes

Primary

MeasureTime frame
Success & failure rate of the intervention done. Success is defined as patient not requiring invasive ventilation after the intervention. Failure is defined as patient requiring invasive ventilation. Timepoint: Assessed from time of admission till 72 hours of intervention—

Secondary

MeasureTime frame
Document complications like abdominal distension, feeding intolerance, nasal mucosal injury, prolonged ICU stay and discharge on oxygen supplementationTimepoint: After starting intervention till discharge or death—

Countries

India

Contacts

Public ContactMotukuri Sesha Sarat Chandra

MGM Medical College, Aurangabad

drkaleav@gmail.com9325212376

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026